The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Atazanavir Accord 300 mg hard capsules

300 milligram(s) Capsule, hard

Accord Healthcare Ireland Ltd.PA2315/193/002

Main Information

Trade NameAtazanavir Accord 300 mg hard capsules
Active SubstancesAtazanavir sulfate
Strength300 milligram(s)
Dosage FormCapsule, hard
Licence HolderAccord Healthcare Ireland Ltd.
Licence NumberPA2315/193/002

Group Information

ATC CodeJ05AE08 atazanavir

Status

Authorised/WithdrawnAuthorised
Licence Issued28/06/2019
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising Status*** AWAITING VALUE ***
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back